Lead researcher and CEO of POP Biotechnologies, Dr. Jonathan Lovell is based at the University at Buffalo. Dr. Lovell said ...

A universal flu vaccine could help avoid the variability in effectiveness seen with current seasonal jabs, which is generally around 60%, but can fall to as low as 10% if health authorities and ...

CSL Seqirus has agreed to provide 665,000 doses of a bird flu vaccine to the European Commission as part of the EU’s efforts to prepare for a potential outbreak of the disease, with an option to ...